Exponent (NASDAQ:EXPO) expects third-quarter fiscal 2026 revenues before reimbursements to increase 8% to 10% year over year. The company also raised its full-year fiscal 2026 outlook and now expects revenues before reimbursements to grow 9% to 10% from fiscal 2025.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.